Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Inventory (2016 - 2025)

CorMedix's Inventory history spans 10 years, with the latest figure at $9.1 million for Q4 2025.

  • For Q4 2025, Inventory rose 19.13% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $9.1 million, up 19.13%, while the annual FY2025 figure was $9.1 million, 19.13% up from the prior year.
  • Inventory for Q4 2025 was $9.1 million at CorMedix, down from $9.2 million in the prior quarter.
  • Across five years, Inventory topped out at $9.6 million in Q2 2025 and bottomed at $269.0 in Q3 2022.
  • The 4-year median for Inventory is $576029.0 (2021), against an average of $3.0 million.
  • The largest annual shift saw Inventory plummeted 99.45% in 2022 before it soared 766.29% in 2025.
  • A 4-year view of Inventory shows it stood at $3008.0 in 2021, then tumbled by 91.06% to $269.0 in 2022, then skyrocketed by 2825178.81% to $7.6 million in 2024, then grew by 19.13% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Inventory are $9.1 million (Q4 2025), $9.2 million (Q3 2025), and $9.6 million (Q2 2025).